Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

近日，美国食品药品监督管理局（FDA）正式批准了由吉利德（Gilead）公司研发的全新艾滋病病毒（HIV）预防药物——来那卡帕韦（Lenacapavir）。这款 ...

艾滋病（AIDS，获得性免疫缺陷综合征）是一种危害极大的传染性疾病，由人类免疫缺陷病毒（HIV，也叫做艾滋病病毒）感染引起，于20世纪80年代首次被发现，一度被视为“绝症”。HIV主要有两种亚型，即HIV-1和HIV-2，相对来讲，HIV-1的复制能 ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

红枫湾APP： firstwordpharma.com消息，默沙东 (也译为默克）的一款长效（ 每月1次 ） 口服 HIV预防药物也宣布进入后期（III期）试验阶段，即将为HIV PrEP（暴露前预防）再添新选择。

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

距离lenacapavir用于HIV预防在美国获批仅8个工作日，这一国际领先的创新药物就在博鳌乐城实现了“全球同步”准入，以“零时差”完成从海外获批到 ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...